Summary
The kinetics of maprotiline have been evaluated in six normal volunteers following rapid intravenous administration of 75 mg. Blood levels could be resolved using a biexponential equation. Mean estimates of half-life, volume of distribution and systemic clearance were 40±15 h, 51.7± 18.01 l/kg and 0.92±0.24 l/kg/h, respectively. Blood/plasma concentrations varied between subjects from 0.77 to 1.64. A comparison of the bioavailability of two oral doses (a 75 mg tablet and three 25 mg tablets) was carried out in the same volunteers. No significant difference was observed between the maprotiline concentrations obtained for the two doses at sampling times up to 26 h. No significant difference was found in the area under the concentration vs. time curves for the two doses. Equivalent bioavailability can be assumed. On the basis of the intravenous injection study, systemic bioavailability averaged 66% and 70% for the 75 mg and three 25 mg tablets respectively.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson B (1972) Pharmacokinetics of desmethyl-imipramine and nortriptyline in man after single and multiple oral doses — a cross over study. Eur J Clin Pharmacol 5: 1–10
Alexanderson B, Borga O (1973) Urinary exeretion of nortripty-line and five of its metabolites in man after single and multiple oral doses. Eur J Clin Pharmacol 5: 174–180
Angst J, Rothweiler R (1973) Blood levels and clinical effects of maprotiline (Ludiomil). In: Classification and prediction of outcome of depression. F. Schattauer Verlag, Stuttgart-New York (Symposia Medica Hoechst, Vol 8, pp 237–244)
Dubois JP, Kung W, Theobald W, Wirz B (1976) Measurement of clomipramine, n-desmethylclomipramine, imipramine and dehydroimipramine in biological fluids by selective ion monitoring and pharmacokinetics of clomipramine. Clin Chem 22: 892–897
Gram F, Fredricson-Overø K (1975) First-pass metabolism of nortriptyline in man. Clin Pharmacol Ther 18: 305–314
Jones RB, Luscombe DK (1977) Single dose study with maprotiline in normal subjects In: Jukes A (ed) Proceedings of an international symposium. Verdala, Malta, Nov 1976. Ciba Laboratories, Horsham, UK, pp 135–143
Maguire KP, Burrows GD, Coghlan JP, Scoggins BA (1976) Rapid radioisotopic procedure for the determination of nortriptyline in plasma. Clin Chem 22: 761–764
Maguire KP, Burrows GD, Norman TR, Scoggins BA (In press 1980) Blood-plasma ratios of psychotropic drugs. Clin Chem
Maitre L, Waldmeier PC, Greengrass PM, Jackel J, Sedlacek S, Delini-Stula A (1975) Maprotiline — its position as an antide-pressant in the light of recent neuropharmacological and neurochemical findings. J. Int Med Res 3: 3–15
Miller PI, Beaumont G, Seldrup J, John V, Luscombe DK, Jones R (1977) Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil). J Int Med Res 5 (Suppl 4): 101–111
Norman TR, Burrows GD, Maguire KP, Scoggins BA (1978) Maprotiline plasma levels and clinical response. Presented at the 11th C.I.N.P. Congress. Vienna, July 9–14, 1978
Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13: 161–228
Riess W, Dubey L, Fungeld EW, Imhof P, Hurzeler H, Matussek N, Rajagopalan TG, Raschdorf F, Schmid K (1975) The pharmacokinetic properties of maprotiline in man. J Int Med Res 3 (Suppl 4): 16–41
Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications Illinois, USA
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maguire, K.P., Norman, T.R., Burrows, G.D. et al. An evaluation of maprotiline intravenous kinetics and comparison of two oral doses. Eur J Clin Pharmacol 18, 249–254 (1980). https://doi.org/10.1007/BF00563007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563007